+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Alpha 1-acid glycoprotein potentiates lipopolysaccharide-induced secretion of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha by human monocytes and alveolar and peritoneal macrophages



Alpha 1-acid glycoprotein potentiates lipopolysaccharide-induced secretion of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha by human monocytes and alveolar and peritoneal macrophages



European Journal of Immunology 22(10): 2687-2695



Although the physiological role of alpha 1-acid glycoprotein (AGP), an acute-phase protein, is poorly understood, several lines of evidence support a modulatory action on the immune response. In this study, we investigated the effect of AGP on the production of interleukin (IL)-1 beta, IL-6 and tumor necrosis factor (TNF)-alpha by human monocytes, macrophages and the monocytic THP-1 cell line. AGP significantly enhanced (2- to 7-fold) the production of these cytokines in monocytes induced by suboptimal concentrations of lipopolysaccharide [E. coli lipopolysaccharide (LPS): 100 ng/ml] in serum-free conditions, whereas it had little or no effect in the absence of LPS. The potentiating effect of AGP was inhibited by specific antibodies. It was concentration dependent and the greatest enhancement was observed with 250-500 micrograms/ml. Moreover, AGP only potentiated the effect of suboptimal concentrations of LPS. AGP did not alter the time course of LPS-induced IL-1 beta, IL-6 or TNF-alpha secretion. AGP acts as a co-inducer and could also potentiate cytokine secretion triggered by Neisseria meningitidis LPS and muramyl dipeptide. The glycan moiety of AGP did not seem to be involved in its potentiating effect, since both its major glycoforms and asialo-AGP potentiated the effect of LPS to the same extent as native AGP. Possible differences in the effect of AGP according to cell maturation were investigated using isolated human macrophages: AGP potentiated LPS-induced cytokine production by both peritoneal and alveolar macrophages. These data suggest that AGP can modulate monocyte/macrophage functions, thereby contributing to the amplification and regulation of immune and inflammatory responses.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 039217684

Download citation: RISBibTeXText

PMID: 1396973

DOI: 10.1002/eji.1830221032


Related references

Interleukin-2-induced tumor necrosis factor-alpha (TNF-alpha) gene expression in human alveolar macrophages and blood monocytes. American Review of Respiratory Disease 139(2): 335-342, 1989

Increased secretion of tumor necrosis factor-alpha, interleukin-1-beta, and interleukin-6 by alveolar macrophages from patients with sarcoidosis. Journal Of Allergy & Clinical Immunology. 91(4): 939-949, 1993

Liposomal muramyl tripeptide up-regulates interleukin-1 alpha, interleukin-1 beta, tumor necrosis factor-alpha, interleukin-6 and interleukin-8 gene expression in human monocytes. Journal of Pharmacology and Experimental Therapeutics 268(2): 1032-1039, 1994

Regulation of monocyte chemoattractant protein-1 gene expression and secretion in rat pulmonary alveolar macrophages by lipopolysaccharide, tumor necrosis factor-alpha, and interleukin-1 beta. American Journal of Respiratory Cell and Molecular Biology 12(1): 104-109, 1995

Interleukin 2 induced tumor necrosis factor alpha gene expression by human alveolar macrophages and blood monocytes. American Review of Respiratory Disease 137(4 Part 2): 89, 1988

Human alveolar macrophage gene expression of interleukin-8 by tumor necrosis factor-alpha, lipopolysaccharide, and interleukin-1 beta. American Journal of Respiratory Cell and Molecular Biology 2(4): 321-326, 1990

Cultured alveolar macrophages from patients with idiopathic pulmonary fibrosis (IPF) show dysregulation of lipopolysaccharide-induced tumor necrosis factor-alpha (TNF-alpha) and interleukin-10 (IL-10) inductions. European Cytokine Network 16(1): 5-16, 2005

The receptor for interleukin 3 is selectively induced in human endothelial cells by tumor necrosis factor alpha and potentiates interleukin 8 secretion and neutrophil transmigration. Proceedings of the National Academy of Sciences of the United States of America 90(23): 11137-11141, 1993

Suppression of tumor necrosis factor-alpha, interleukin-1 beta, interleukin-6 and granulocyte-monocyte colony stimulating factor secretion from human monocytes by an extract of Poria cocos. Zhonghua Minguo Wei Sheng Wu Ji Mian Yi Xue Za Zhi 25(1): 1-11, 1992

Expression of messenger rna of interleukin 1 alpha beta and tumor necrosis factor alpha in human alveolar macrophages from patients with pulmonary sarcoidosis and fibrosis. Immunobiology 175(1-2): 100, 1987

Inhibition of tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta) secretion but not IL-6 from activated human peripheral blood monocytes by a new synthetic demethylpodophyllotoxin derivative. Journal of Clinical Immunology 14(5): 280-288, 1994

Interleukin 2 il 2 stimulates the production of interleukin 1 beta il 1 beta interleukin 1 alpha il 1 alpha and tumor necrosis factor alpha tnf alpha from human peripheral blood mononuclear cells pbmc. Journal of Leukocyte Biology 42(5): 545, 1987

Regulation of interleukin-1ra, interleukin-1 alpha, and interleukin-1 beta production by human alveolar macrophages with phorbol myristate acetate, lipopolysaccharide, and interleukin-4. American Journal of Respiratory Cell and Molecular Biology 8(2): 160-168, 1993

Interleukin 10 (Il-10) regulation of tumour necrosis factor alpha (Tnf-alpha) from human alveolar macrophages and peripheral blood monocytes. Thorax 51(2): 143-149, 1996

Regulation of the bradykinin receptors by interleukin-1-beta, tumor necrosis factor-alpha and lipopolysaccharide in dependence on the activity state of guinea pig peritoneal macrophages. Naunyn-Schmiedeberg's Archives of Pharmacology 353(4 Suppl. ): R95, 1996